Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis B Virus Gene Therapy
Study results from People's Hospital broaden understanding of hepatitis B virus gene therapy
April 8th, 2008
Scientists discuss in 'RNAi for treating hepatitis B viral infection' new findings in hepatitis B virus. According to a study from People's Republic of China, "Chronic hepatitis B virus (HBV) infection is one of the leading causes of liver cirrhosis and hepatocellular carcinoma (HCC). Current treatment strategies of HBV infection including the use of interferon (IFN)-alpha and nucleotide analogues such as lamivudine and adefovir have met with only partial success." "Therefore, it is necessary to develop more effective antiviral therapies that can clear HBV infection with fewer side effects. RNA interference (RNAi), by which a small interfering RNA (siRNA) induces the...
Source: Cancer Weekly (2008-04-08)
|
